Snehjeev Ventures crosses 9% stake in Amerise Biosciences via open market
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts more than Nifty Microcap 250 and 1.7 pts more than its Plastic Products - Industrial peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Snehjeev Ventures Pvt Ltd along with PACs Rushankss, Sneha, Riddhi and Sanjeev Lunkad acquired 28,000 equity shares (0.04%) of Amerise Biosciences Ltd on 20 July 2026 through open market purchases. Their combined holding rose from 8.98 percent (59.34 lakh shares) to 9.02 percent (59.62 lakh shares). The acquirer is not part of the promoter group. Filing made under Reg 29(2) of SEBI Takeover Regulations as the 9 percent disclosure threshold was crossed.
Non-promoter entity creeping toward 10 percent trigger limit; further disclosures expected if 10 percent is crossed.